Stoke Therapeutics, Inc. (STOK)

NASDAQ: STOK · USD

$26.4

+0.29 (+1.1%)· Recorded snapshot

Market cap	1.7B
Revenue (ttm)	27.6M
Net income (ttm)	-207.9M
EPS (ttm)	-$3.33
Shares out	64.5M
Volume	599,912
Beta	1.26

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 27.6M
Net income (ttm): -207.9M
EPS (ttm): -$3.33
Market cap: 1.7B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantener

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.4P50 20.2P75 35.7

Trailing P/En/a

P25 15.4P50 25.8P75 43.5

ROE-61.1

P25 -113.8P50 -46.5P75 -0.9

ROIC-405.5

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All STOK indicators

Market & fundamental data

Available fields

204

Groups with data

Currency

USD

Showing 204 of 204 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001623526
Company name	Stoke Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	86150R107
Earnings date	2026-10-29
Earnings time	amc
Employees	170
Employees change	42
Employees growth	32.81%
Enterprise value	$1.4B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2014
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2019-06-19
Is primary listing	Yes
Is SPAC	No
ISIN number	US86150R1077
Last 10-K release date	2026-03-16
Last earnings date	2026-08-03
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$1.7B
Market cap category	Small-Cap
Next earnings date	2026-10-29
Options	Yes
Price	$26.42
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	STOK
U.S. state	Massachusetts
Website	https://www.stoketherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-12.61%
EV/Sales	48.67x
FCF / EV yield	-13.46%
FCF yield	-10.66%
Forward EV/Sales	44.52x
Forward P/S	56.18x
P/B ratio	4.72x
P/S ratio	61.42x
Price / tangible book value	4.9x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Operating margin	-809.69%
Pretax margin	-758.23%
Profit per employee	$-1.2M
Revenue per employee	$162,282
ROA	-35.87%
ROA (5Y)	-21.02%
ROCE	-63.45%
ROE	-61.1%
ROE (5Y)	-38.65%
ROIC	-405.53%
SBC / revenue	135.72%
Tax / revenue	-4.63%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	3
Gross profit growth	-86.2%
Gross profit growth (Q)	-32.51%
Gross profit growth 3Y	46.11%
Net income growth years	2
Revenue growth	-86.2%
Revenue growth (Q)	-32.51%
Revenue growth (QoQ)	49.7%
Revenue growth 3Y	46.11%
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-2.7M
Depreciation and amortization	$1.7M
EBIT	$-223.4M
EBITDA	$-221.6M
EPS	$-3.33
FCF per share	$-2.80
Financing cash flow	$181.7M
Free cash flow	$-180.7M
Free cash flow minus SBC	$-218.1M
Gross profit	$27.6M
Income taxes	$-1.3M
Investing cash flow	$7.7M
Net cash flow	$11.5M
Net income	$-207.9M
Operating cash flow minus SBC	$-215.4M
Operating income	$-223.4M
Revenue	$27.6M
Stock-based compensation	$37.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	16.92
Book value per share	$5.54
Debt / equity	0.01
Interest coverage	-4,752.7
Long-term assets	$71.4M
Long-term liabilities	$6.5M
Net cash (debt)	$351.6M
Net cash / market cap	20.75%
Net cash growth	0.06%
Net debt / equity	-1.02
Piotroski F-Score	2
Property, plant and equipment	$6.7M
Shareholders' equity	$345.5M
Tangible book value	$345.5M
Tangible book value per share	$5.54
Total assets	$394M
Total cash	$292.8M
Total debt	$2.7M
Total liabilities	$48.4M
WACC	11.18%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.07
Current assets	$322.5M
Current liabilities	$41.9M
Current ratio	7.69
Net working capital	$-10.4M
Quick ratio	7.19
Working capital	$280.6M
Working capital turnover	0.11

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-7.27%
Dividend yield	0%
Shareholder yield	-7.27%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$30.35
1D price change	1.11%
1M price change	6.53%
1M total return	6.53%
1W price change	2.88%
1W total return	2.88%
1Y price change	-19.94%
1Y return CAGR	-19.95%
1Y total return	-19.94%
20-day SMA	$24.94
200-day SMA	$30.96
3M price change	-9.86%
3M total return	-9.86%
3Y price change	683.98%
3Y return CAGR	98.63%
3Y total return	683.98%
50-day SMA	$27.67
50-day SMA vs 200-day SMA	50under200
52-week high	$40.22
52-week high date	2026-03-10
52-week low	$20.32
52-week low date	2025-11-05
5Y price change	9.4%
5Y return CAGR	1.81%
5Y total return	9.4%
6M price change	-21.63%
6M total return	-21.63%
All-time high	$71.58
All-time high date	2021-01-20
All-time low	$3.35
All-time low date	2023-10-27
Average true range (ATR)	$1.26
Average volume	1.2M
Beta (1Y)	1.15
Beta (2Y)	1.74
Beta (5Y)	1.26
Change from 52-week high	-34.31%
Change from 52-week low	30.02%
Change from all-time high	-63.09%
Change from all-time low	688.66%
Change from open	1.46%
Day's gap	-0.34%
Dollar volume	$15.8M
High price	$26.45
Low price	$26.04
Monthly RSI	54.17
Open price	$26.04
Position in 52-week range	92.68%
Premarket change	0.08%
Premarket close	$26.13
Premarket price	$26.15
Premarket volume	133
Previous close	$26.13
Price vs 150-day SMA	-12.95%
Price vs 20-day SMA	5.92%
Price vs 200-day SMA	-14.67%
Price vs 50-day SMA	-4.5%
Relative volume	0.53
Return from IPO open	-3.49%
Return from IPO price	45.89%
RSI	53.11
Sharpe ratio	-0.18
Sharpe ratio (3Y)	1.15
Sharpe ratio (5Y)	0.38
Sortino ratio	-0.16
Sortino ratio (3Y)	2.19
Sortino ratio (5Y)	0.67
Volume	599.9K
Weekly RSI	43.69
YTD price change	-16.76%
YTD total return	-16.76%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	45.6M
Float percentage	70.69%
Shares change (QoQ)	4.68%
Shares change (YoY)	7.27%
Shares held by insiders	3.71%
Shares held by institutions	95.54%
Shares outstanding	64.5M
Short % of float	25.22%
Short % of shares	17.83%
Short ratio	12.5 days

Deeper analysis on STOK

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this STOK report

Is a complete STOK research report available?

No complete published report is available for Stoke Therapeutics, Inc. (STOK) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Stoke Therapeutics, Inc. (STOK)

Price

Financial snapshot

Fair-value bridge

Latest news · STOK

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All STOK indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on STOK

Frequently asked questions